Fintel reports that on March 9, 2026, Northland Capital Markets upgraded their outlook for Everpure (NYSE:PSTG) from Market Perform to Outperform. Analyst Price Forecast Suggests 54.02% Upside As of February 25, 2026, the average one-year price target for Everpure is $93.80/share. The forecasts range from a low of $60.60 to a high of $110.25. The average price target represents an increase of 54.0...
Fintel reports that on March 9, 2026, Northland Capital Markets upgraded their outlook for Everpure (NYSE:PSTG) from Market Perform to Outperform. Analyst Price Forecast Suggests 54.02% Upside As of February 25, 2026, the average one-year price target for Everpure is $93.80/share. The forecasts range from a low of $60.60 to a high of $110.25. The average price target represents an increase of 54.02% from its latest reported closing price of $60.90 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Everpure is 3,958MM, an increase of 8.06%. The projected annual non-GAAP EPS is 2.10, an increase of 20.02% from the prior forecast. What is the Fund Sentiment? There are 949 funds or institutions reporting positions in Everpure. This is an decrease of 353 owner(s) or 27.11% in the last quarter. Average portfolio weight of all funds dedicated to PSTG is 0.15%, an increase of 38.88%. Total shares owned by institutions decreased in the last three months by 10.94% to 282,030K shares. The put/call ratio of PSTG is 0.53, indicating a bullish outlook. What are Other Shareholders Doing? Geode Capital Management holds 7,716K shares representing 2.34% ownership of the company. In its prior filing, the firm reported owning 7,509K shares , representing an increase of 2.69%. The firm decreased its portfolio allocation in PSTG by 20.51% over the last quarter. Disciplined Growth Investors holds 4,897K shares representing 1.48% ownership of the company. In its prior filing, the firm reported owning 5,160K shares , representing a decrease of 5.37%. The firm decreased its portfolio allocation in PSTG by 19.83% over the last quarter. Atreides Management holds 4,178K shares representing 1.27% ownership of the company. In its prior filing, the firm reported owning 4,098K shares , representing an increase of 1.90%. The firm decreased its portfolio allocation in PSTG by 48.86% over the last quarter. Arrowstreet Capital, Limited Partn...
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Alger’s Ankur Crawford, United Nations Assistant Secretary General Kirsi Madi, Petrobras CEO Magda Chambriard, Panama Canal Authority Administrator Dr. Ricaurte Vásquez Morales, J.P. Morgan Asset Management’s Stephanie Aliaga,...
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Alger’s Ankur Crawford, United Nations Assistant Secretary General Kirsi Madi, Petrobras CEO Magda Chambriard, Panama Canal Authority Administrator Dr. Ricaurte Vásquez Morales, J.P. Morgan Asset Management’s Stephanie Aliaga, Meredith Whitney Advisory Group CEO Meredith Whitney, Council on Foreign Relations’ Shannon O’Neil, National Center for Energy Analytics Visiting Fellow Neil Atkinson, & Neuberger Berman’s Ashok Bhatia. (Source: Bloomberg)
In the latest trading session, Shell (SHEL) closed at $85.59, marking a +1.05% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.83%. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%. Shares of the oil and gas company witnessed a gain of 12.5% over the previous month, beating the performance of the Oils-Energy se...
In the latest trading session, Shell (SHEL) closed at $85.59, marking a +1.05% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.83%. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%. Shares of the oil and gas company witnessed a gain of 12.5% over the previous month, beating the performance of the Oils-Energy sector with its gain of 7.08%, and the S&P 500's loss of 2.65%. The investment community will be paying close attention to the earnings performance of Shell in its upcoming release. The company's earnings per share (EPS) are projected to be $1.71, reflecting a 7.07% decrease from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $69.15 billion, showing a 1.42% drop compared to the year-ago quarter. SHEL's full-year Zacks Consensus Estimates are calling for earnings of $6.29 per share and revenue of $271.25 billion. These results would represent year-over-year changes of -0.16% and -0.91%, respectively. Investors should also note any recent changes to analyst estimates for Shell. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 2.17% higher. As of now, Shell holds a Zacks Rank of #3 (Hold). Valuation is also important, so investors should note that Shell has a Fo...
Intrusion Inc. (INTZ) closed the most recent trading day at $1.09, moving +2.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.83% for the day. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%. The stock of company has risen by 15.22% in the past month, leading the Computer and Technology s...
Intrusion Inc. (INTZ) closed the most recent trading day at $1.09, moving +2.83% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.83% for the day. Meanwhile, the Dow experienced a rise of 0.5%, and the technology-dominated Nasdaq saw an increase of 1.38%. The stock of company has risen by 15.22% in the past month, leading the Computer and Technology sector's loss of 3.51% and the S&P 500's loss of 2.65%. Investors will be eagerly watching for the performance of Intrusion Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on March 24, 2026. The company is predicted to post an EPS of -$0.09, indicating a 75% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.06 million, up 22.32% from the year-ago period. For the full year, the Zacks Consensus Estimates are projecting earnings of -$0.41 per share and revenue of $7.67 million, which would represent changes of +74.85% and +32.82%, respectively, from the prior year. It is also important to note the recent changes to analyst estimates for Intrusion Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Intrusion Inc. presently features a Zacks Rank of #3 (H...
In the latest trading session, NXP Semiconductors (NXPI) closed at $205.25, marking a +1.74% move from the previous day. This change outpaced the S&P 500's 0.83% gain on the day. Meanwhile, the Dow gained 0.5%, and the Nasdaq, a tech-heavy index, added 1.38%. Shares of the chipmaker witnessed a loss of 10.07% over the previous month, trailing the performance of the Computer and Technology sector w...
In the latest trading session, NXP Semiconductors (NXPI) closed at $205.25, marking a +1.74% move from the previous day. This change outpaced the S&P 500's 0.83% gain on the day. Meanwhile, the Dow gained 0.5%, and the Nasdaq, a tech-heavy index, added 1.38%. Shares of the chipmaker witnessed a loss of 10.07% over the previous month, trailing the performance of the Computer and Technology sector with its loss of 3.51%, and the S&P 500's loss of 2.65%. The investment community will be paying close attention to the earnings performance of NXP Semiconductors in its upcoming release. In that report, analysts expect NXP Semiconductors to post earnings of $2.98 per share. This would mark year-over-year growth of 12.88%. Meanwhile, our latest consensus estimate is calling for revenue of $3.12 billion, up 9.99% from the prior-year quarter. In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $13.93 per share and a revenue of $13.44 billion, indicating changes of +17.95% and +9.58%, respectively, from the former year. Investors should also take note of any recent adjustments to analyst estimates for NXP Semiconductors. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.8% higher. NXP Semiconductors presently features a Zacks Rank of #2 (Buy). In terms of...
Medpace (MEDP) ended the recent trading session at $389.41, demonstrating a +0.79% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.11%. At the same time, the Dow lost 0.3%, and the tech-heavy Nasdaq gained 0.56%. The the stock of provider of outsourced clinical development services has fallen by 1.59% in the past month, lagging the M...
Medpace (MEDP) ended the recent trading session at $389.41, demonstrating a +0.79% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily gain of 0.11%. At the same time, the Dow lost 0.3%, and the tech-heavy Nasdaq gained 0.56%. The the stock of provider of outsourced clinical development services has fallen by 1.59% in the past month, lagging the Medical sector's gain of 2.86% and the S&P 500's gain of 5.06%. Market participants will be closely following the financial results of Medpace in its upcoming release. The company's earnings per share (EPS) are projected to be $2.52, reflecting a 30.57% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $529.73 million, up 14.94% from the prior-year quarter. For the full year, the Zacks Consensus Estimates project earnings of $11.29 per share and a revenue of $2.17 billion, demonstrating changes of +27.14% and +14.92%, respectively, from the preceding year. It's also important for investors to be aware of any recent modifications to analyst estimates for Medpace. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.53% upward. Medpace currently has a Zacks Rank of #1 (Strong Buy). In the context of valuation, Medpace is at pr...
Rithm (RITM) closed the latest trading day at $11.26, indicating a +1.26% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.23%. Elsewhere, the Dow lost 0.17%, while the tech-heavy Nasdaq added 0.34%. Shares of the real estate investment trust witnessed a loss of 3.81% over the previous month, trailing the performance of the Finance sect...
Rithm (RITM) closed the latest trading day at $11.26, indicating a +1.26% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily gain of 0.23%. Elsewhere, the Dow lost 0.17%, while the tech-heavy Nasdaq added 0.34%. Shares of the real estate investment trust witnessed a loss of 3.81% over the previous month, trailing the performance of the Finance sector with its loss of 0.44% and the S&P 500's gain of 3.96%. The investment community will be paying close attention to the earnings performance of Rithm in its upcoming release. The company is predicted to post an EPS of $0.42, indicating a 32.26% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $1.13 billion, showing an 8.86% escalation compared to the year-ago quarter. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.76 per share and revenue of $4.82 billion. These totals would mark changes of -14.56% and +33.16%, respectively, from last year. Investors should also pay attention to any latest changes in analyst estimates for Rithm. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Rithm is hold...
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%. Elsewhere, the Dow gained 0.38%, while the tech-heavy Nasdaq added 0.25%. Prior to today's trading, shares of the electronics manufacturer had gained 11.87% over the past month. This has outpaced the Comput...
The latest trading session saw Jabil (JBL) ending at $162.64, denoting a +1.03% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.53%. Elsewhere, the Dow gained 0.38%, while the tech-heavy Nasdaq added 0.25%. Prior to today's trading, shares of the electronics manufacturer had gained 11.87% over the past month. This has outpaced the Computer and Technology sector's loss of 0.75% and the S&P 500's gain of 1.24% in that time. Market participants will be closely following the financial results of Jabil in its upcoming release. The company's earnings per share (EPS) are projected to be $1.81, reflecting a 7.74% increase from the same quarter last year. Meanwhile, the latest consensus estimate predicts the revenue to be $6.41 billion, indicating a 5.25% decrease compared to the same quarter of the previous year. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $8.78 per share and revenue of $27.35 billion. These totals would mark changes of +3.42% and -5.31%, respectively, from last year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Jabil. These latest adjustments often mirror the shifting dynamics of short-term business patterns. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.33% increase. J...
Social Security is an important source of money for most retirees. That's the point, as the system was set up to ensure retirees had a basic level of income on which to live. The dilemma you face is deciding when to start claiming Social Security. Here's the big reason to claim early. When can you claim Social Security? You pay into the Social Security system all of your working life. And when you...
Social Security is an important source of money for most retirees. That's the point, as the system was set up to ensure retirees had a basic level of income on which to live. The dilemma you face is deciding when to start claiming Social Security. Here's the big reason to claim early. When can you claim Social Security? You pay into the Social Security system all of your working life. And when you stop working, you can start claiming the entitlement. The system is set up so you have a retirement age that varies based on when you were born. Some people will have a full retirement age of 65, while others will end up at 67. That is when you get your full benefit. However, you can claim as early as age 62 or wait until age 70. (Technically, you don't have to claim Social Security at all, if you don't want to.) If you claim early, your benefits are reduced for life. If you claim late, your benefits are higher for life. From a pure dollars-and-cents view, the right decision is to wait until 70 so you maximize your Social Security check. The reason why people claim at 62 That said, there's a spike in claims at 62. In fact, more people claim at 62 than at any other age. This actually makes sense in one very important way: Nobody knows when they will die. If you wait until 70 to claim Social Security, you are gambling that you will not only live to age 70 but also well beyond that age, as well. If you have significant retirement savings, that may not be a big deal for you, as you can live off of your savings until you claim. However, if you don't have material retirement savings, delaying would likely require you to continue working. But you have to consider what you are giving up by not claiming: the opportunity to stop working. You could enjoy that time doing things you love instead of earning an income so you can delay collecting Social Security. Life is what happens while you are busy doing other things The average life expectancy in the United States is around 78. On av...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Meta Platforms (NasdaqGS:META) has signed a multi-year AI content licensing deal with News Corp to train and improve its AI models. The company is pursuing multibillion dollar, multi-year agreements with Nvidia, AMD, and Google for advanced chips and AI infr...
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Meta Platforms (NasdaqGS:META) has signed a multi-year AI content licensing deal with News Corp to train and improve its AI models. The company is pursuing multibillion dollar, multi-year agreements with Nvidia, AMD, and Google for advanced chips and AI infrastructure. Meta is expanding its own data center footprint and creating a new applied AI engineering team to support generative AI development. Meta Platforms, the parent of Facebook, Instagram, WhatsApp, and Threads, is moving quickly to secure the data, compute power, and engineering talent it needs for generative AI. For investors watching large technology and communication platforms, this cluster of agreements and initiatives around content, chips, and infrastructure points to AI as a core priority across the business. For you, the key question is how this step up in AI resources might shape Meta's products, cost base, and competitive position over the next several years. The combination of content deals, chip partnerships, and new internal teams could influence how its apps evolve, how users interact with AI features, and how Meta compares with other large tech platforms that are also investing heavily in similar capabilities. Stay updated on the most important news stories for Meta Platforms by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Meta Platforms. NasdaqGS:META Earnings & Revenue Growth as at Mar 2026 We've flagged 0 risks for Meta Platforms. See which could impact your investment. Quick Assessment ✅ Price vs Analyst Target : At US$647.39, Meta trades about 25% below the consensus analyst price target of US$862.25. ✅ Simply Wall St Valuation : Simply Wall St estimates Meta is trading roughly 42.4% below its fair value. ❌ Recent Momentum: The share price has had a 2.1% decline over the last 30 da...
Rafmaster/iStock via Getty Images PagSeguro Digital Ltd. ( PAGS ) has reported Q4 '25 results . The quarter looked broadly similar to previous reads, with very little growth in payments, a lot of growth in credit, higher financial expenses from both rates and capital optimization, and better EPS than net income because the share count keeps falling. For 2026, management again expects the same broa...
Rafmaster/iStock via Getty Images PagSeguro Digital Ltd. ( PAGS ) has reported Q4 '25 results . The quarter looked broadly similar to previous reads, with very little growth in payments, a lot of growth in credit, higher financial expenses from both rates and capital optimization, and better EPS than net income because the share count keeps falling. For 2026, management again expects the same broad pattern: strong credit growth, modest gross profit growth, and double-digit EPS growth, even before additional buybacks. The challenges remain a pressured payments business and increasing reliance on credit for growth. I believe these challenges are more than compensated for by a stock that still trades at about 6x my estimate of 2026 earnings while also returning a meaningful amount of capital to shareholders. I maintain a Buy rating. Q4 '25 Results The core trend in the quarter did not change from previous reads . Payments remain stable, but they are a clearly mature business, while banking keeps growing fast enough to offset that slowdown at the company level. TPV was still soft every year, down 2.5% in 4Q25, although it rose ~10% sequentially. The sequential improvement might mark the first real sign of reacceleration after a weak year. Cash-in, which is one of the better indicators of banking engagement outside credit, rose 11% to R$90.7 billion, while deposits increased ~13% to ~R$41 billion. The payments business continues to trend towards more competition, slower, if any, growth, and more pressured profitability. Payment revenues rose only 5.6% YoY. Given that TPV was down for the year, this still signals a healthy take rate. Still, on a sequential basis, TPV rebounded almost 10%, but payment revenues rose only 4.6%, indicating potential challenges. The most profitable legacy activity, merchant prepayments, was up only 1% YoY. This remains a very good business, but it no longer looks like a clear growth engine. On the other hand, we have exploding banking activity...
In early March 2026, CVS Health and Google Cloud announced a long-term partnership to power CVS’s new Health100 platform with Gemini-based AI, secure cloud infrastructure, and interoperable data tools to create real-time, omni-channel health engagement for consumers and partners across the healthcare ecosystem. The Health100 collaboration uniquely positions Google Cloud at the center of an open, A...
In early March 2026, CVS Health and Google Cloud announced a long-term partnership to power CVS’s new Health100 platform with Gemini-based AI, secure cloud infrastructure, and interoperable data tools to create real-time, omni-channel health engagement for consumers and partners across the healthcare ecosystem. The Health100 collaboration uniquely positions Google Cloud at the center of an open, AI-enabled health data network that could deepen its enterprise footprint while testing consumer trust in high-stakes, privacy-sensitive use cases. We’ll now examine how this Health100 AI healthcare partnership may influence Alphabet’s investment narrative, especially its heavy AI infrastructure spending. Uncover the next big thing with 29 elite penny stocks that balance risk and reward. Alphabet Investment Narrative Recap To own Alphabet today, you have to believe its massive AI and cloud buildout can justify record capital spending while its ad-heavy core stays resilient. The CVS Health100 deal reinforces the main near term catalyst, which is Google Cloud’s role as AI infrastructure for large enterprises, but it does little to reduce the biggest risk: whether outsized AI data center capex will earn attractive returns if demand or pricing weakens. Among recent announcements, the AES partnership in Texas stands out alongside Health100, because both highlight Alphabet’s push to support AI growth with long term, energy efficient infrastructure. Together they underline how much of the Alphabet story now runs through Google Cloud and Gemini, where success could help offset pressure on ad margins, but also amplify the financial impact if AI investment or usage trends fall short of expectations. Yet beneath this AI optimism, investors should be aware of growing scrutiny of Alphabet’s data use and AI safety practices, which could... Read the full narrative on Alphabet (it's free!) Alphabet's narrative projects $512.6 billion revenue and $148.4 billion earnings by 2028. This require...